IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gilead Sciences, Inc.

Q1 2026 Holdings

Filed 2026-05-08 | 6 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcellx Inc(ACLX)COM03940C100$771.7M6,720,80336.4%
Arcus Biosciences Inc(RCUS)COM03969F109$678.8M31,424,76032.1%
Galapagos NV(GLPG)SPON ADR36315X101$501.2M16,707,47723.7%
Assembly Biosciences Inc(ASMB)COM NEW045396207$125.0M4,505,3915.9%
Kyverna Therapeutics Inc(KYTX)COM501976104$35.6M4,126,1191.7%
Xilio Therapeutics Inc(XLO)COM98422T100$5.5M650,3890.3%